2 Pre-existing ocular or neurological disease that might affect bilateral visual fields or interfere with perimetry e.g. aphakia visually significant cataract glaucoma diabetes mellitus ischemic optic neuropathy multiple sclerosis Patients with stable visual field defects from CNS lesions e.g. epilepsy surgery more than 6 months prior to receiving Sabril may be enrolled 